GE Equity

GE Equity invests globally across various sectors, focusing on established companies with high growth potential. It takes minority ownership positions and offers growth capital, buy-out co-investments, secondary direct purchases, recapitalizations, and LP investments.

Keith Miller

Senior Vice President

Ned Reynolds

Director, Media Relations - Americas

Past deals in North Carolina

Micell Technologies

Series B in 2009
Micell Technologies, Inc. is a biomedical device company specializing in interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in Raleigh, North Carolina, the company develops innovative products such as the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System, which combines the benefits of a drug-eluting stent with those of a bare-metal stent. Micell also offers drug-coated balloons that deliver sirolimus to the artery wall during procedures like percutaneous transluminal angioplasty, as well as bioresorbable scaffolds for controlled drug delivery. Utilizing advanced technologies, Micell aims to enhance healing and improve clinical outcomes in the treatment of cardiovascular diseases. Additionally, the company provides clinical trials and health economics services to support its product development and market strategies.

Micell Technologies

Series A in 2007
Micell Technologies, Inc. is a biomedical device company specializing in interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in Raleigh, North Carolina, the company develops innovative products such as the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System, which combines the benefits of a drug-eluting stent with those of a bare-metal stent. Micell also offers drug-coated balloons that deliver sirolimus to the artery wall during procedures like percutaneous transluminal angioplasty, as well as bioresorbable scaffolds for controlled drug delivery. Utilizing advanced technologies, Micell aims to enhance healing and improve clinical outcomes in the treatment of cardiovascular diseases. Additionally, the company provides clinical trials and health economics services to support its product development and market strategies.

LipoScience

Series F in 2006
LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

LipoScience

Series E in 2003
LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

Buildnet

Series B in 1999
Buildnet offers management software to homebuilders. Its product, BuildNet, Inc. Exchange, provides internet-based procurement, e-commerce, and information services to homebuilders, suppliers, and manufacturers. Buildnet is based in Durham, North Carolina, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.